The Clinical Course and Outcomes of Patients Hospitalized Due to COVID-19 during Three Pandemic Waves in Poland: A

Carlo Bieńkowski1,2, Justyna D Kowalska1,2, Marcin Paciorek1,2

  • 1Hospital for Infectious Diseases in Warsaw, 01-201 Warsaw, Poland.

Insights

Patients hospitalized with COVID-19 during Poland's third pandemic wave experienced more severe illness and worse outcomes, including higher rates of serious complications and death.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • The first case of COVID-19 in Poland was reported on March 4, 2020.
  • This study focuses on patients hospitalized at the Hospital for Infectious Diseases in Warsaw.

Purpose of the Study:

  • To compare the clinical course and outcomes of COVID-19 patients across three pandemic waves.
  • To analyze demographic and clinical data of hospitalized COVID-19 patients in Warsaw.

Main Methods:

  • Retrospective analysis of 2138 COVID-19 patient records from March 2020 to November 2021.
  • COVID-19 diagnosis confirmed via RT-PCR or antigen testing.
  • Pandemic waves defined by case numbers and dynamics.

Main Results:

  • The third wave cohort (n=2138) had lower oxygen saturation and higher oxygen supplementation needs.
  • Increased incidence of pneumothorax, thromboembolic events, ICU admission, and mortality observed in the third wave.
  • Majority of patients were male (57.8%), median age 65 years.

Conclusions:

  • COVID-19 patients during the third wave in Warsaw faced a more severe disease course.
  • Outcomes were poorer for patients hospitalized during the third pandemic wave.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
344
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
417
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
300
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
58.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
414
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K